What TRT Actually Did for Me at 53
I was diagnosed with anxiety in 2021, hit 373 lbs in 2024, and started TRT in 2025. The full story, the numbers, and what the discourse misses.
Fitness Journey, Medicine 3.0, Testosterone/TRT
Fitness Journey, Medicine 3.0
Reading Your Cholesterol Panel at 50: A Plain-English Guide to the New 2026 Guideline
Your cholesterol panel at 50, decoded. The six numbers, the new 2026 guideline targets, the coronary calcium scan, and what the drugs actually do.
Fitness Journey, GLP-1, Medicine 3.0
SURMOUNT-MAINTAIN: The Trial I Wanted on Tirzepatide Dose Reduction
I am at goal weight on Zepbound. SURMOUNT-MAINTAIN is the trial I have been waiting for. Here is what holding the line at a lower dose actually looks like.
cardio, Longevity
Cycling Cuts Dementia Risk by 22%. What the New Data Actually Says.
A study of 479,000 adults found cyclists had 22% lower Alzheimer’s risk, 40% lower young-onset dementia risk, and measurably larger hippocampi than nonactive controls. Here’s what the data actually shows, the APOE caveat the headlines missed, and the negative RCT you should hold next to it.
Bloodwork, Cholesterol, Longevity, Medicine 3.0
Lp(a) Test: The Number Most Doctors Miss
In May 2026, three major papers landed on Lp(a) — the genetic cholesterol marker that 1 in 5 adults carry at risk levels and almost nobody gets tested for. Here’s what the new evidence says, what to do if your number is high, and the aspirin advice you should stop following.
Cholesterol
The Weird History of Statins: Mold, Muscle Pain, and the Nocebo Effect
I knew statins worked. I did not know how strange the origin story was. How statins started with mold The first statin came from Akira Endo, a Japanese biochemist who grew up fascinated by fungi and was inspired by the discovery of penicillin. After spending time in New York in the 1960s, he was struck
Weight loss
Foundayo on Medicare: $50 Coverage Through the GLP-1 Bridge
If you have Medicare and your doctor has been telling you about a new daily pill for weight loss, this post is for you. Foundayo is real, it’s FDA-approved, and starting July 1, 2026, it’s covered for $50 a month under Medicare’s GLP-1 Bridge program for eligible beneficiaries. This is genuinely new. Foundayo got FDA
Weight loss
Wegovy, Zepbound and Foundayo on Medicare for $50: How to Qualify for the GLP-1 Bridge Before July 1, 2026
Starting July 1, 2026, Medicare will cover Wegovy, Zepbound and Foundayo for obesity at a $50 monthly copay. The program is real, it’s called the Medicare GLP-1 Bridge, and it runs through December 31, 2027. I’m lucky — my employer’s insurance covers Zepbound, and I’ve been on it long enough to learn the system the
Weight loss
Zepbound vs Grey Market Tirzepatide: At 15mg, Branded Is Cheaper (April 2026)
Quick disclosure first. I take Zepbound at 12.5mg, prescribed by my doctor and covered by insurance. If the coverage went away tomorrow I’d be on LillyDirect cash-pay before the end of the week. That’s where I’m coming from. I admit I am fascinated by the rise of peptides. It’s as much a business story as
Longevity, Medicine 3.0
At Some Point, Biohacking Just Becomes Shopping
I read a USA Today story this week about the rise of “biohacking,” and my first reaction was that it mostly got the vibe right. More wearables. More self-ordered labs. More biological-age tests. More longevity clinics. More guys showing up with a screen full of numbers and the feeling that they’re finally getting serious about